Medical Device News Magazine

Wearable Medical Devices Market to grow by USD 15.54 billion from 2022 to 2027 | Market is Fragmented Due to the Presence of Prominent Companies Like Abbott Laboratories, Alphabet Inc., Apple Inc. & More

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

Wearable Medical Devices Market

The wearable medical devices market is estimated to grow by USD 15.54 billion from 2022 to 2027, growing at a CAGR of 17.82%. The wearable medical devices market is fragmented owing to the presence of many global and regional companies. A few prominent companies that offer wearable medical devices market are 3L Labs Co. Ltd., Abbott Laboratories, Alphabet Inc., Apple Inc., Biotricity Inc., Boston Scientific Corp., Daifuku Co. Ltd., Dexcom Inc., Garmin Ltd., General Electric Co., Huawei Technologies Co. Ltd., Johari Digital India Ltd., Koninklijke Philips N.V., Medtronic Plc, OMRON Corp., Oura Health Oy, Polar Electro Oy, Samsung Electronics Co. Ltd., The Sotera Wireless Inc., and ten3T Healthcare.

The report provides a full list of key companies, their strategies, and the latest developments.

Company Offering:

  • Abbott Laboratories – The company offers wearable medical devices such as wearable FreeStyle Libre devices.
  • Alphabet Inc. – The company offers wearable medical devices such as the Fitbit series under its subsidiary called Google LLC.
  • Apple Inc. – The company offers wearable medical devices such as the Apple Watch series to measure blood oxygen levels.
  • For details on companies and their offerings – Buy the report!

By Geography, the market is classified as North America, Europe, Asia, and Rest of World (ROW). North America will have the largest share of the market. The region is estimated to contribute 37% to the growth of the global market during the forecast period. The rising incidence of diseases, a high prevalence of hearing impairment, an increase in the number of technological devices used for wearables, increasing GDP, increased healthcare spending, new product launches and significant market presence of large companies are some of the major factors driving the growth in the region.

  • Impactful driver- Increasing prevalence of chronic diseases globally
  • Key Trend – Emergence of innovative wearable medical devices
  • Major Challenges – High cost of wearable medical devices

Market Segmentation

  • The diagnostic and monitoring devices segment is estimated to witness significant growth during the forecast period. These devices enable the detection and monitoring of changes in body signatures throughout various areas and organs, thus making them a major advantage. Furthermore, factors such as the increasing health consciousness among end-users, the launch of low-cost wearable vital signs and activity monitoring devices, and technological advancements are also positively impacting the growth of this segment.
  • Related Reports:The diagnostic wearable medical devices market size is estimated to grow by USD 7,333.3 million at a CAGR of 15.2% between 2022 and 2027.The wearable pulse oximeters market is estimated to grow by USD 244.66 million at a CAGR of 7.3% between 2023 and 2027.
Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Shoulder Innovations Further Strengthens IP Portfolio in Key Areas with Recent Patent Grants

"These recent grants further strengthen key patent families that are foundational to our technology, and we are pleased the USPTO continues to recognize our meaningful innovation in the shoulder arthroplasty segment," said Rob Ball, CEO of Shoulder Innovations. "This noteworthy expansion of our IP position represents the culmination of over 10 years of research and development, and we are proud of our team for their continued dedication to creating practical solutions for shoulder surgeons and advancing patient outcomes."

Radical Catheter Technologies Presents Analysis of Disruptive, Recently FDA-Cleared Endovascular Technology at the Society of NeuroInterventional Surgery 21st Annual Meeting

This new catheter, the first product commercialized from this novel technology platform, is designed to enable access to the blood vessels in the brain for both femoral and radial access. A multi-center analysis of this disruptive technology is being presented today at Society of NeuroInterventional Surgery 21st annual meeting. In addition, the Company confirmed the closing of a $20 million financing round led by NeuroTechnology Investors, which will be used to scale the company and expand the Radical platform notes Radical Catheter Technologies.

Rapid Medical™ Completes Initial Neurovascular Cases in the USA Following FDA Clearance of Its Active Access Solution

“With DRIVEWIRE, our design goal was to bring new levels of access and control to the interventional suite while improving best-in-class guidewires,” comments Giora Kornblau, Chief Technology Officer at Rapid Medical. “When physicians are looking for technologies that increase the clinical possibilities and safety for the patient, we want Rapid to be the first place they look.”